Welsh Carson Anderson & Stowe

Welsh, Carson, Anderson & Stowe is a leading private equity firm forming ongoing partnerships with management teams across Technology and Healthcare. Founded in 1979, the firm is headquartered in New York, NY, with an additional office in San Francisco, and has raised over $34 billion across 18 funds. Beyond capital, WCAS provides functional expertise in growth strategy, talent and culture-building, technology enablement, and M&A sourcing, positioning itself as a hands-on partner of choice for executives and investors. Its technology focus spans data and information services, edtech, fintech, govtech, governance/risk/compliance, HCM, payments, real estate, and supply chain management; healthcare coverage spans care delivery, HCIT, payor services and risk-based care, and the pharma value chain. Notable current and past portfolio companies include Fiserv, Norstella, Clearwater Analytics, Asurion, Avetta, GovCIO, Quickbase, Shields Health Solutions, EquiLend, and Lumexa Imaging, which completed its IPO in early 2026. Its investment criteria center on category-leading or category-defining businesses in healthcare and technology; its approach is long-term and partnership-driven, emphasizing organic growth, operational improvement, and strategic M&A over four-plus decades of experience.